{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:15:18Z","timestamp":1781151318655,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijpharm.2018.02.027","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T17:49:57Z","timestamp":1518803397000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The use of fatty acids as absorption enhancer for pulmonary drug delivery"],"prefix":"10.1016","volume":"541","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7371-9505","authenticated-orcid":false,"given":"Maliheh","family":"Ghadiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finbarr","family":"Canney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pacciana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-017X","authenticated-orcid":false,"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.02.027_b0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/exd.12750","article-title":"Modulation of transepithelial electric resistance (TEER) in reconstructed human epidermis by excipients known to permeate intestinal tight junctions","volume":"24","author":"Abdayem","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1018909210879","article-title":"Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route","volume":"10","author":"Anderberg","year":"1993","journal-title":"Pharm. Res. Dordr."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1476-511X-13-142","article-title":"Combination of unsaturated fatty acids and ionizing radiation on human glioma cells: cellular, biochemical and gene expression analysis","volume":"13","author":"Antal","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11095-015-1804-1","article-title":"Drug permeation characterization of inhaled dry powder formulations in air-liquid interfaced cell layer using an improved, simple apparatus for dispersion","volume":"33","author":"Asai","year":"2016","journal-title":"Pharm. Res. Dordr."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cbi.2009.06.016","article-title":"Fatty acids increase paracellular absorption of aluminium across Caco-2 cell monolayers","volume":"181","author":"Aspenstrom-Fagerlund","year":"2009","journal-title":"Chemico-biol. Interact."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci. Us"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12248-011-9307-4","article-title":"Absorption enhancers: applications and advances","volume":"14","author":"Aungst","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0005-2736(76)90137-1","article-title":"Modification of the fatty acid composition of Ehrlich ascites tumor cell plasma membranes","volume":"426","author":"Awad","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0045","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/c3fo60036j","article-title":"Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions","volume":"4","author":"Beguin","year":"2013","journal-title":"Food Funct."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1211\/jpp.60.5.0002","article-title":"Pharmaceutical and pharmacological importance of peptide transporters","volume":"60","author":"Brandsch","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ejpb.2014.10.008","article-title":"A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells","volume":"88","author":"Brayden","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejpb.2015.05.013","article-title":"Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol","volume":"94","author":"Brayden","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1517\/17425247.5.6.641","article-title":"Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines","volume":"5","author":"Bur","year":"2008","journal-title":"Expert. Opin. Drug Del."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0070","first-page":"1726","article-title":"Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells","volume":"39","author":"Burns","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(99)00213-6","article-title":"In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology","volume":"191","author":"Chao","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0169-409X(00)00047-8","article-title":"Modification of tight junction function by protein kinase C isoforms","volume":"41","author":"Clarke","year":"2000","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.102.047654","article-title":"Acute mechanism of medium chain fatty acid-induced enhancement of airway epithelial permeability","volume":"305","author":"Coyne","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0090","first-page":"69","article-title":"Omega 3 and omega 6 fatty acids in human and animal health: an African perspective","volume":"398","author":"Dunbar","year":"2014","journal-title":"Mol. CellEndocrinol"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/09687680210139839","article-title":"Gap junctions: structure and function (Review)","volume":"19","author":"Evans","year":"2002","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11095-007-9527-6","article-title":"Myosin light chain kinase inhibition: Correction of increased intestinal epithelial permeability in vitro","volume":"25","author":"Feighery","year":"2008","journal-title":"Pharm. Res. Dordr."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0105","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1166\/jnn.2015.10341","article-title":"Breathable medicine: pulmonary mode of drug delivery","volume":"15","author":"Gandhimathi","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"G\u00fcnzel","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0120","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3109\/03639041003695113","article-title":"Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model","volume":"36","author":"Haghi","year":"2010","journal-title":"Drug Dev. Indus. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0125","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2337\/diacare.23.9.1343","article-title":"Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer","volume":"23","author":"Heinemann","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0168-3659(94)90072-8","article-title":"Mechanisms of absorption enhancement and tight junction regulation","volume":"29","author":"Hochman","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0135","first-page":"52","article-title":"Effects of spray adjuvants on spray droplet size from a rotary atomizer","volume":"1587","author":"Hoffmann","year":"2016","journal-title":"Am Soc. Test. Mater."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2003.10.001","article-title":"Absorption enhancers in pulmonary protein delivery","volume":"94","author":"Hussain","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0145","unstructured":"Joint-FAO-WHO-Expert-Comm-Food, 2011. Evaluation of certain food additives and contaminants Seventy-fourth report of the Joint FAO\/WHO Expert Committee on Food Additives Introduction. Who Tech Rep Ser 966, 1-+."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0150","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/bcp.12557","article-title":"Lessons learned from the clinical development of oral peptides","volume":"79","author":"Karsdal","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2012.06554.x","article-title":"Barriers and more: functions of tight junction proteins in the skin","volume":"1257","author":"Kirschner","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0160","first-page":"29","article-title":"Influence of polyunsaturated fatty acids on intestinal barrier function during colitis","volume":"21","author":"Knoch","year":"2010","journal-title":"Agro Food Ind. Hi Tech"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0165","unstructured":"Lai, Y.T., Lo, C.M., 2014. Assessing in vitro cytotoxicity of cell micromotion by Hilbert-Huang Transform. 2014 36th Annual International Conference of the Ieee Engineering in Medicine and Biology Society (Embc), pp. 3200\u20133203."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/00365519509104978","article-title":"Effect of free fatty-acids on the structure and properties of erythrocyte-membrane","volume":"55","author":"Lapshina","year":"1995","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0175","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.bbamem.2009.04.002","article-title":"The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes","volume":"1788","author":"Leekumjorn","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1742-4658.2007.06210.x","article-title":"Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis","volume":"275","author":"Li","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0185","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.molimm.2007.09.003","article-title":"n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines","volume":"45","author":"Li","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0190","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)37216-7","article-title":"Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells","volume":"284","author":"Lindmark","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0195","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.addr.2004.02.006","article-title":"Membrane transporter\/receptor-targeted prodrug design: strategies for human and veterinary drug development","volume":"56","author":"Majumdar","year":"2004","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/jam.2004.17.335","article-title":"Next generation pharmaceutical impactor: A new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15 L\/min","volume":"17","author":"Marple","year":"2004","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0205","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1176822","article-title":"Safety concerns over the use of intestinal permeation enhancers: a mini-review","volume":"4","author":"McCartney","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0210","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jps.2600760709","article-title":"Analysis of Structural Requirements for the Absorption of Drugs and Macromolecules from the Nasal Cavity","volume":"76","author":"McMartin","year":"1987","journal-title":"J. Pharm. Sci.-Us"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0215","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/mp100050d","article-title":"Enabling the intestinal absorption of highly polar anti-viral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir","volume":"7","author":"Miller","year":"2010","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/pr.55.3.1","article-title":"Impact of drug transporter studies on drug discovery and development","volume":"55","author":"Mizuno","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0970-2113.92361","article-title":"Pulmonary drug delivery strategies: a concise, systematic review","volume":"29","author":"Patil","year":"2012","journal-title":"Lung India"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0230","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/erd.09.43","article-title":"Challenges and advances in nanoparticle-based oral insulin delivery","volume":"6","author":"Ramesan","year":"2009","journal-title":"Expert Rev. Med. Device"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0235","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jps.20051","article-title":"Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate","volume":"93","author":"Raoof","year":"2004","journal-title":"J. Pharm. Sci. Us"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02405019","article-title":"A model for trans-cellular transport of calcium based on membrane fluidity and movement of calcium carriers within the more fluid microdomains of the plasma-membrane","volume":"35","author":"Reith","year":"1983","journal-title":"Calcified Tissue Int."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0245","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1021\/bi00482a019","article-title":"Ca2+, Mg2+, Li+, Na+, and K+ distributions in the headgroup region of binary membranes of phosphatidylcholine and phosphatidylserine as seen by deuterium NMR","volume":"29","author":"Roux","year":"1990","journal-title":"Biochem. Us"},{"key":"10.1016\/j.ijpharm.2018.02.027_b9005","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/jps.21653","article-title":"Preparation and evaluation of controlled release microparticles for respiratory protein therapy","volume":"98","author":"Salama","year":"2009","journal-title":"J. Pharm. Sci.-Us"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0250","first-page":"283","article-title":"Cyclodextrins as mucosal absorption promoters of insulin. 3. Pulmonary route of delivery","volume":"40","author":"Shao","year":"1994","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/BTER:75:1-3:215","article-title":"Lanthanides enhance pulmonary absorption of insulin","volume":"75","author":"Shen","year":"2000","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2015.05.270","article-title":"Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation","volume":"210","author":"Taverner","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0265","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1023\/A:1015992819290","article-title":"Enhancement of colonic drug absorption by the trans-cellular permeation route","volume":"5","author":"Tomita","year":"1988","journal-title":"Pharm. Res. Dordr."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0270","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2217\/nnm-2017-0188","article-title":"Inhaled simvastatin nanoparticles for inflammatory lung disease","volume":"12","author":"Tulbah","year":"2017","journal-title":"Nanomed.-Uk"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0275","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1211\/0022357021779159","article-title":"Effect of dietary fatty acids on the intestinal permeability of marker drug compounds in excised rat jejunum","volume":"54","author":"Vine","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0280","first-page":"147","article-title":"Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells","volume":"61","author":"Wu","year":"2007","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0285","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jphp.12274","article-title":"Improvement of pulmonary absorptions of poorly absorbable drugs using Gelucire 44\/14 as an absorption enhancer","volume":"66","author":"Zhang","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0290","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijpharm.2015.05.020","article-title":"Improvement of pulmonary absorption of poorly absorbable macromolecules by hydroxypropyl-beta-cyclodextrin grafted polyethylenimine (HP-beta-CD-PEI) in rats","volume":"489","author":"Zhang","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.027_b0295","doi-asserted-by":"crossref","first-page":"e0116888","DOI":"10.1371\/journal.pone.0116888","article-title":"A Cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-\u03b2(1)","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2018.02.027_b0300","first-page":"448","article-title":"Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers","volume":"67","author":"Zheng","year":"2012","journal-title":"Pharmazie"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731830108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731830108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:57:23Z","timestamp":1751407043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731830108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":61,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S037851731830108X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.027","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of fatty acids as absorption enhancer for pulmonary drug delivery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}